Hydrochloric Acid → 2-(2-Morpholinyl)-4,5,6,7-tetrahydro-1H-benzimidazole
反応式
C1(C[N:8]2[CH2:13][CH2:12][O:11][CH:10]([C:14]3[NH:18][C:17]4[CH2:19][CH2:20][CH2:21][CH2:22][C:16]=4[N:15]=3)[CH2:9]2)C=CC=CC=1.Cl>C(O)C.[Pd]>[NH:8]1[CH2:13][CH2:12][O:11][CH:10]([C:14]2[NH:15][C:16]3[CH2:22][CH2:21][CH2:20][CH2:19][C:17]=3[N:18]=2)[CH2:9]1参加物
5
実験手順
2-[4-(Phenylmethyl)-2-morpholinyl]-4,5,6,7-tetrahydro-1H-benzimidazole (0.78 g, 2.62 mmol) was hydrogenated in ethanol (30 mL) in the presence of Pd/C (10 wt %, 0.279 g, 0.262 mmol). To the reaction mixture was added 0.2 mL of concentrated hydrochloric acid. After stirring at room temperature overnight, the catalyst was filtered off. The filtrate was concentrated to afford the title compound (0.8 g) as a yellow oil. LC-MS (ES) m/z=208 [M+H]+.
後処理
- filtrationthe catalyst was filtered off
- concentrationThe filtrate was concentrated
出典と根拠
- ORDレコード
- ord-49179edbbc5e499aaebf2cf1e331f81e
- 出典データセット
- uspto-grants-2014_04
- 特許番号
- US08697685B2
反応ノート
読み込み中…